|
1
|
Fantuzzi G: Adipose tissue, adipokines,
and inflammation. J Allergy Clin Immunol. 115:911–919. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Conde J, Scotece M, Gómez R, et al:
Adipokines: biofactors from white adipose tissue. A complex hub
among inflammation, metabolism, and immunity. Biofactors.
37:413–420. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ouchi N, Parker JL, Lugus JJ and Walsh K:
Adipokines in inflammation and metabolic disease. Nat Rev Immunol.
11:85–97. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hotta K, Funahashi T, Arita Y, et al:
Plasma concentrations of a novel, adipose-specific protein,
adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc
Biol. 20:1595–1599. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kadowaki T, Yamauchi T, Kubota N, et al:
Adiponectin and adiponectin receptors in insulin resistance,
diabetes, and the metabolic syndrome. J Clin Invest. 116:1784–1792.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Toussirot E, Gaugler B, Bouhaddi M, et al:
Elevated adiponectin serum levels in women with systemic autoimmune
diseases. Mediators Inflamm. 2010:9384082010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang EH, Lee YJ, Kim TK, et al:
Adiponectin is a potential catabolic mediator in osteoarthritis
cartilage. Arthritis Res Ther. 12:R2312010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Koskinen A, Juslin S, Nieminen R, et al:
Adiponectin associates with markers of cartilage degradation in
osteoarthritis and induces production of proinflammatory and
catabolic factors through mitogen-activated protein kinase
pathways. Arthritis Res Ther. 13:R1842011. View Article : Google Scholar
|
|
9
|
Rho YH, Solus J, Sokka T, et al:
Adipocytokines are associated with radiographic joint damage in
rheumatoid arthritis. Arthritis Rheum. 60:1906–1914. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Aǧbaht K, Gürlek A, Karakaya J and
Bayraktar M: Circulating adiponectin represents a biomarker of the
association between adiposity and bone mineral density. Endocrine.
35:371–379. 2009.PubMed/NCBI
|
|
11
|
Doherty AL, Battaglino RA, Donovan J, et
al: Adiponectin is a candidate biomarker of lower extremity bone
density in men with chronic spinal cord injury. J Bone Miner Res.
29:251–259. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Magni P, Dozio E, Galliera E, Ruscica M
and Corsi MM: Molecular aspects of adipokine-bone interactions.
Curr Mol Med. 10:522–532. 2010.PubMed/NCBI
|
|
13
|
Mohiti-Ardekani J, Soleymani-Salehabadi H,
Owlia MB and Mohiti A: Relationships between serum adipocyte
hormones (adiponectin, leptin, resistin), bone mineral density and
bone metabolic markers in osteoporosis patients. J Bone Miner
Metab. 32:400–404. 2014. View Article : Google Scholar
|
|
14
|
Jim JJ, Noponen-Hietala N, Cheung KM, et
al: The TRP2 allele of COL9A2 is an age-dependent risk factor for
the development and severity of intervertebral disc degeneration.
Spine (Phila Pa 1976). 30:2735–2742. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin WP, Wang XJ, Wang CR, et al:
Polymorphism in the hypoxia-inducible factor 1alpha gene may confer
susceptibility to LDD in Chinese cohort. PLoS One. 8:e731582013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Näkki A, Videman T, Kujala UM, et al:
Candidate gene association study of magnetic resonance
imaging-based hip osteoarthritis (OA): evidence for COL9A2 gene as
a common predisposing factor for hip OA and lumbar disc
degeneration. J Rheumatol. 38:747–752. 2011.PubMed/NCBI
|
|
17
|
Seki S, Kawaguchi Y, Mori M, et al:
Association study of COL9A2 with lumbar disc disease in the
Japanese population. J Hum Genet. 51:1063–1067. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Solovieva S, Lohiniva J, Leino-Arjas P, et
al: Intervertebral disc degeneration in relation to the COL9A3 and
the IL-1ss gene polymorphisms. Eur Spine J. 15:613–619. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zawilla NH, Darweesh H, Mansour N, et al:
Matrix metalloproteinase-3, vitamin D receptor gene polymorphisms,
and occupational risk factors in lumbar disc degeneration. J Occup
Rehabil. 24:370–381. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khabour OF, Mesmar FS, Alatoum MA,
Gharaibeh MY and Alzoubi KH: Associations of polymorphisms in
adiponectin and leptin genes with men’s longevity. Aging Male.
13:188–193. 2010.
|
|
21
|
Khabour OF, Wehaibi SH, Al-Azzam SI,
Alzoubi KH and El-Akawi ZJ: Association of adiponectin with
hypertension in type 2 diabetic patients: the gender effect. Clin
Exp Hypertens. 35:361–366. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Al-Azzam SI, Alkhateeb AM, Alzoubi KH, et
al: Atorvastatin treatment modulates the interaction between leptin
and adiponectin, and the clinical parameters in patients with type
II diabetes. Exp Ther Med. 6:1565–1569. 2013.PubMed/NCBI
|
|
23
|
Nedvidkova J, Smitka K, Kopsky V and
Hainer V: Adiponectin, an adipocyte-derived protein. Physiol Res.
54:133–140. 2005.
|
|
24
|
Gomez R, Lago F, Gomez-Reino J, Dieguez C
and Gualillo O: Adipokines in the skeleton: influence on cartilage
function and joint degenerative diseases. J Mol Endocrinol.
43:11–18. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kanazawa I: Adiponectin in metabolic bone
disease. Curr Med Chem. 19:5481–5492. 2012. View Article : Google Scholar
|
|
26
|
Ruscica M, Steffani L and Magni P:
Adiponectin interactions in bone and cartilage biology and disease.
Vitam Horm. 90:321–339. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Giles JT, van der Heijde DM and Bathon JM:
Association of circulating adiponectin levels with progression of
radiographic joint destruction in rheumatoid arthritis. Ann Rheum
Dis. 70:1562–1568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Klein-Wieringa IR, van der Linden MP,
Knevel R, et al: Baseline serum adipokine levels predict
radiographic progression in early rheumatoid arthritis. Arthritis
Rheum. 63:2567–2574. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Senolt L, Pavelka K, Housa D and Haluzik
M: Increased adiponectin is negatively linked to the local
inflammatory process in patients with rheumatoid arthritis.
Cytokine. 35:247–252. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang F, Wang PX, Wu XL, et al: Deficiency
of adiponectin protects against ovariectomy-induced osteoporosis in
mice. PLoS One. 8:e684972013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Johansson H, Oden A, Lerner UH, et al:
High serum adiponectin predicts incident fractures in elderly men:
Osteoporotic fractures in men (MrOS) Sweden. J Bone Miner Res.
27:1390–1396. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lago R, Gomez R, Otero M, et al: A new
player in cartilage homeostasis: adiponectin induces nitric oxide
synthase type II and pro-inflammatory cytokines in chondrocytes.
Osteoarthritis Cartilage. 16:1101–1109. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Barbour KE, Zmuda JM, Boudreau R, et al:
Adipokines and the risk of fracture in older adults. J Bone Miner
Res. 26:1568–1576. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Eglit T, Lember M, Ringmets I and Rajasalu
T: Gender differences in serum high-molecular-weight adiponectin
levels in metabolic syndrome. Eur J Endocrinol. 168:385–391. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Al-Daghri NM, Al-Attas OS, Alokail MS, et
al: Gender differences exist in the association of leptin and
adiponectin levels with insulin resistance parameters in
prepubertal Arab children. J Pediatr Endocrinol Metab. 24:427–432.
2011.PubMed/NCBI
|
|
36
|
Tabatabaei-Malazy O, Hasani-Ranjbar S,
Amoli MM, et al: Gender-specific differences in the association of
adiponectin gene polymorphisms with body mass index. Rev Diabet
Stud. 7:241–246. 2010.PubMed/NCBI
|
|
37
|
Haluzik M, Parizkova J and Haluzik MM:
Adiponectin and its role in the obesity-induced insulin resistance
and related complications. Physiol Res. 53:123–129. 2004.PubMed/NCBI
|
|
38
|
Hoffstedt J, Arvidsson E, Sjolin E, Wahlen
K and Arner P: Adipose tissue adiponectin production and
adiponectin serum concentration in human obesity and insulin
resistance. J Clin Endocrinol Metab. 89:1391–1396. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Trevaskis JL, Gawronska-Kozak B, Sutton
GM, et al: Role of adiponectin and inflammation in insulin
resistance of Mc3r and Mc4r knockout mice. Obesity (Silver Spring).
15:2664–2672. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hashemi M, Hanafi Bojd H, Eskandari Nasab
E, et al: Association of adiponectin rs1501299 and rs266729 gene
polymorphisms with nonalcoholic fatty liver disease. Hepat Mon.
13:e95272013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Hsiao TJ, Wu LS, Huang SY and Lin E: A
common variant in the adiponectin gene on weight loss and body
composition under sibutramine therapy in obesity. Clin Pharmacol.
2:105–110. 2010.
|
|
42
|
Rizk NM, El-Menyar A, Marei I, et al:
Association of adiponectin gene polymorphism (+T45G) with acute
coronary syndrome and circulating adiponectin levels. Angiology.
64:257–265. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Younossi ZM, Jarrar M, Nugent C, et al: A
novel diagnostic biomarker panel for obesity-related nonalcoholic
steatohepatitis (NASH). Obes Surg. 18:1430–1437. 2008. View Article : Google Scholar : PubMed/NCBI
|
